Objective: To estimate the risk for persons treated with antidepressants or lithium of
subsequent treatment with antiparkinson drugs (APD). Methods: The Danish national …

Background: Individuals with depression have a higher risk of Parkinson's disease (PD) but
the timing of the association is unknown. Therefore, the relationship between initiation of …

Introduction Few epidemiological studies have assessed the risk of parkinsonisms after
prolonged use of neuroleptics. We aimed to examine the long-term risk of degenerative …

Background Depression is considered one of the prodromal symptoms of Parkinson's
disease (PD) along with sleep disorders, hyposmia and constipation. Prodromal symptoms …

We estimated the nationwide prevalence rate of antidepressant drug treatment in
Parkinson's disease (PD) patients. BACKGROUND: Very few studies exist on the frequency …

Objective. Psychosis is a common complication of the drug treatment of Parkinson's disease
(PD). Treatment of this complication is difficult as most antipsychotic drugs worsen motor …

To compare the risk of occurrence of “serious” extrapyramidal symptoms (EPS) between
selective serotonin reuptake inhibitors and other antidepressant drugs in patients with …

Depressive symptoms and major depression are frequent in patients with Parkinson's
disease (PD). However, a systematic knowledge about the treatment with antidepressant …

Objective: Neuroleptics and neuroleptic-like drugs are known to induce parkinsonism, which
may reveal underlying Parkinson disease (PD) in some cases. We assessed the long-term …

Introduction It has been suggested that depression in Parkinson's Disease (PD) is often
unrecognized and undertreated. However, few previous studies have studied the use of …